Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Stellbrink, Hans-Jurgen"" wg kryterium: Autor


Tytuł :
Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials
Autorzy :
Cassetti, Lidia
David, Daniel
Figueras, Laura
Losso, Marcelo
Lopardo, Gustavo
Lupo, Sergio
Porteiro, Norma
Sánchez, Marisa
Bloch, Mark
Cooper, David
Finlayson, Robert
Kelleher, Anthony
Koh, Kenneth
Lewis, David
McMahon, James
Moore, Richard
Roth, Norman
Shields, Matthew
De Wit, Stephane
Florence, Eric
Goffard, Jean-Christophe
Demeester, Remy
Lacor, Patrick
Vandercam, Bernard
Vandekerckhove, Linos
Angel, Jonathan
Baril, Jean-Guy
Conway, Brian
De Pokomandy, Alexandra
Szabo, Jason
Walmsley, Sharon
Bouchaud, Olivier
Chidiac, Christian
Delobel, Pierre
Goujard, Cecile
Katlama, Christine
Molina, Jean-Michel
Pialoux, Gilles
Philibert, Patrick
Bogner, Johannes
Esser, Stefan
Krznaric, Ivanka
Lehmann, Clara
Spinner, Christoph
Stellbrink, Hans-Jurgen
Stephan, Christoph
Stoehr, Albrecht
Barchi, Enrico
Caramello, Pietro
Castelli, Francesco
Cattelan, Anna Maria
D'Arminio Monforte, Antonella
Di Biagio, Antonio
Di Perri, Giovanni
Gori, Andrea
Maggiolo, Franco
Menzaghi, Barbara
Migliorino, Guglielmo
Mussini, Cristina
Penco, Giovanni
Puoti, Massimo
Rizzardini, Giuliano
Gulminetti, Roberto
Lazzarin, Adriano
Quirino, Tiziano
Sighinolfi, Laura
Viale, Pierluigi
Amaya Tapia, Gerardo
Andrade Villanueva, Jaime
Granados Reyes, Enrique R
Perez Rios, Alma
Santoscoy Gomez, Mario
Den Hollander, Jan
Rijnders, Bart
Hidalgo, José A
Hercilla Vasquez, Luis
Illescas, Luis
Olczak, Anita
Mansinho, Kamal
Correia Pacheco, Patricia Paula
Teófilo, Eugénio
Saraiva da Cunha, Jose
Sarmento e Castro, Rui
Serrão, Rosário
Arbune, Manuela
Jianu, Cristian
Oprea, Anca
Preotescu, Liliana
Prisacariu, Liviu-Jany
Belonosova, Elena
Borodkina, Olga
Chernova, Oxana
Gankina, Natalia
Kizhlo, Svetlana
Kulagin, Valeriy
Kurina, Nadezhda
Nagimova, Firaya
Pokrovsky, Vadim
Ryamova, Elena
Voronin, Evgeny
Yakovlev, Alexey
Kaplan, Richard
Lee, Sun Hee
Kim, Shin-Woo
Kim, Sang-Il
Kim, Woo Joo
Antela Lopez, Antonio
Casado Osorio, Jose L
Castaño Carracedo, Manuel A
De Los Santos Gil, Ignacio
Estrada Perez, Vicente
Falco Ferrer, Vicenç
Force, Luis
Galinda Puerto, Maria Jose
Garcia Deltoro, Miguel
Gatell, Josep M
Goenaga Sanchez, Miguel A
González Cordón, Ana
Knobel, Hernando
Lopez Bernaldo de Quiros, Juan Carlos
Losa Garcia, Juan E
Masia, Mar
Montero-Alsonso, Marta
Ocampo Hermida, Antonio
Pasquau Liaño, Juan
Portilla Sogorb, Joaquin
Pulido Ortega, Federico
Rivera Roman, Antonio
Santos Fernandez, Jose Ramon
Torres Perea, Rafael
Troya Garcia, Jesus
Viciana Fernandez, Pompeyo
Calmy, Alexandra
Hauser, Christoph
Fehr, Jan
Cheng, Shu-Hsing
Ko, Wen-Chien
Lin, Hsi-Hsun
Lu, Po-Liang
Tseng, Yu-Ting
Wang, Ning-Chi
Wong, Wing-Wai
Yang, Chia-Jui
Arduino, Roberto
Benson, Paul
Berhe, Mezgebe
Bredeek, Fritz
Brinson, Cynthia
Campbell, Thomas
Crofoot, Gordon
Cunningham, Douglas
DeJesus, Edwin
Dretler, Robin
Eron, Joseph
Fife, Kenneth
Fichtenbaum, Carl
Flamm, Jason
Goldstein, Deborah
Gupta, Samir
Hagins, Debbie
Hoffman-Terry, Margaret
Jayaweera, Dushyantha
Kinder, Clifford
Klein, Daniel
McDonald, Cheryl
Mills, Anthony
Nahass, Ronald
Osiyemi, Olayemi
Overton, Edgar
Parks, David
Prelutsky, David
Ramgopal, Moti
Schrader, Shannon
Sha, Beverly
Simon, Gary
Sims, James
Skiest, Daniel
Slim, Jihad
Tashima, Karen
Thedinger, Blair
Gazzard, Brian
Fox, Julie
Johnson, Margaret
Kegg, Stephen
Khoo, Saye
Mazhude, Charles
Orkin, Chloe
Schembri, Gabriel
Ustianowski, Andrew
Cahn, Pedro
Pokaż więcej
Źródło :
In The Lancet 12-18 January 2019 393(10167):143-155
Czasopismo naukowe
Tytuł :
Treatment modification after starting cART in people living with HIV: retrospective analysis of the German ClinSurv HIV Cohort 2005-2017.
Autorzy :
Stecher M; Department I for Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Herderstraße 52-54, 50931, Cologne, Germany. .; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany. .
Schommers P; Department I for Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Herderstraße 52-54, 50931, Cologne, Germany.; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.
Kollan C; Robert-Koch Institute (RKI), Berlin, Germany.
Stoll M; Department of Clinical Immunology and Rheumatology, Hannover Medical School, Hannover, Germany.
Kuhlendahl F; Ifi-Institute for Interdisciplinary Medicine, Hamburg, Germany.
Stellbrink HJ; Infectious Disease Medical Center, Hamburg, Germany.
Wasmuth JC; Department I for Internal Medicine, University Hospital of Bonn, Bonn, Germany.; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Bonn, Germany.
Stephan C; Department of Infectious Diseases, University Hospital Frankfurt, Goethe-University, Frankfurt am Main, Germany.
Hamacher L; Department I for Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Herderstraße 52-54, 50931, Cologne, Germany.
Lehmann C; Department I for Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Herderstraße 52-54, 50931, Cologne, Germany.; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.
Boesecke C; Department I for Internal Medicine, University Hospital of Bonn, Bonn, Germany.
Bogner J; Section for Infectious Diseases, Medical Clinic and Polyclinic IV, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.
Esser S; Clinic of Dermatology, Department of Venerology, University Hospital Essen, Essen, Germany.
Fritzsche C; Department of Tropical Medicine and Infectious Diseases, University of Rostock, Rostock, Germany.
Haberl A; Department of Infectious Diseases, University Hospital Frankfurt, Goethe-University, Frankfurt am Main, Germany.
Hoffmann C; ICH Study Center, Infektionsmedizinisches Centrum Hamburg, Hamburg, Germany.
Jensen B; Department of Gastroenterology, Hepatology and Infectiology, University of Düsseldorf, Düsseldorf, Germany.
Schwarze-Zander C; Department I for Internal Medicine, University Hospital of Bonn, Bonn, Germany.
Platten M; Labor Dr. Wisplinghoff, Cologne, Germany.
Fätkenheuer G; Department I for Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Herderstraße 52-54, 50931, Cologne, Germany.; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany.
Schmidt D; Robert-Koch Institute (RKI), Berlin, Germany.; Charité - University Medicine Berlin, Berlin, Germany.
Gunsenheimer-Bartmeyer B; Robert-Koch Institute (RKI), Berlin, Germany.
Vehreschild JJ; Department I for Internal Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Herderstraße 52-54, 50931, Cologne, Germany. .; German Center for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany. .; Department of Hematology and Oncology, Johann Wolfgang Goethe University of Frankfurt, Frankfurt am Main, Germany. .
Pokaż więcej
Corporate Authors :
ClinSurv Study Group
Źródło :
Infection [Infection] 2020 Oct; Vol. 48 (5), pp. 723-733. Date of Electronic Publication: 2020 Jul 01.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Efficacy and Safety of Switching to Dolutegravir With Boosted Darunavir in Virologically Suppressed Adults With HIV-1: A Randomized, Open-Label, Multicenter, Phase 3, Noninferiority Trial: The DUALIS Study.
Autorzy :
Spinner CD; Technical University of Munich, School of Medicine, University Hospital Rechts der Isar, Munich, Germany.
Kümmerle T; Private Practice, Ebertplatz, Germany.
Schneider J; Technical University of Munich, School of Medicine, University Hospital Rechts der Isar, Munich, Germany.
Cordes C; Private Practice, Berlin, Germany.
Heiken H; Private Practice, Georgstrasse, Hannover, Germany.
Stellbrink HJ; ICH Study Center, Hamburg, Germany.
Krznaric I; Private Practice, Zentrum für Infektiologie Prenzlauer Berg, Berlin, Germany.
Scholten S; Private Practice, Hohenstaufenring, Köln, Germany.
Jensen B; University Hospital Düsseldorf, Düsseldorf, Germany.
Wyen C; Private Practice, Ebertplatz, Germany.; Department of Internal Medicine I, University Hospital Cologne, Cologne, Germany.
Viehweger M; Private Practice, Berlin, Germany.
Lehmann C; Department of Internal Medicine I, University Hospital Cologne, Cologne, Germany.
Sprinzl M; Department of Medicine I, University Hospital Mainz, Mainz, Germany.
Stoehr A; Private Practice, IfI Institute, Hamburg, Germany.
Bickel M; Private Practice, Infektiologiukum, Frankfurt, Germany.
Jessen H; Private Practice, Jessen2, Berlin, Germany.
Obst W; Department of Gastroenterology, University Hospital Magdeburg, Magdeburg, Germany.
Spornraft-Ragaller P; University Hospital Dresden, Fetscherstr, Germany.
Khaykin P; Private Practice, MainFachArzt, Frankfurt, Germany.
Wolf E; MUC Research Clinical Research Organization (CRO), Munich, Germany.
Boesecke C; Bonn University Hospital, Bonn, Germany.
Pokaż więcej
Corporate Authors :
DUALIS Study Group
Źródło :
Open forum infectious diseases [Open Forum Infect Dis] 2020 Aug 13; Vol. 7 (9), pp. ofaa356. Date of Electronic Publication: 2020 Aug 13 (Print Publication: 2020).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Short-term neuropsychiatric tolerability of bictegravir combined with emtricitabine/tenofovir alafenamide in clinical practice.
Autorzy :
Hoffmann C; ICH Study Center Hamburg, Hamburg, Germany.; Department of Medicine II, University of Schleswig-Holstein, Campus Kiel, Kiel, Germany.
Schewe K; ICH Study Center Hamburg, Hamburg, Germany.
Fenske S; ICH Study Center Hamburg, Hamburg, Germany.
Buhk T; ICH Study Center Hamburg, Hamburg, Germany.
Sabranski M; ICH Study Center Hamburg, Hamburg, Germany.
Adam A; ICH Study Center Hamburg, Hamburg, Germany.
Hansen S; ICH Study Center Hamburg, Hamburg, Germany.
Stellbrink HJ; ICH Study Center Hamburg, Hamburg, Germany.
Pokaż więcej
Źródło :
Antiviral therapy [Antivir Ther] 2020 Apr 01. Date of Electronic Publication: 2020 Apr 01.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Physical and mental health in HIV-infected patients with virological success and long-term exposure to antiretroviral therapy.
Autorzy :
Sabranski M; ICH Study Center, Hamburg, Germany.
Erdbeer G; Department of Medicine II, University of Schleswig-Holstein, Campus Kiel, Germany.
Sonntag I; Department of Medicine II, University of Schleswig-Holstein, Campus Kiel, Germany.
Stoehr A; IFI Institute for Interdisciplinary Medicine, Hamburg, Germany.
Horst HA; Department of Medicine II, University of Schleswig-Holstein, Campus Kiel, Germany.
Plettenberg A; IFI Institute for Interdisciplinary Medicine, Hamburg, Germany.
Lebherz L; Department of Medical Psychology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Stellbrink HJ; ICH Study Center, Hamburg, Germany.
Hoffmann C; ICH Study Center, Hamburg, Germany.; Department of Medicine II, University of Schleswig-Holstein, Campus Kiel, Germany.
Pokaż więcej
Źródło :
AIDS care [AIDS Care] 2020 Feb 27, pp. 1-9. Date of Electronic Publication: 2020 Feb 27.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Renal safety of tenofovir alafenamide vs. tenofovir disoproxil fumarate: a pooled analysis of 26 clinical trials.
Autorzy :
Gupta SK; Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Post FA; King's College Hospital NHS Foundation Trust, London, UK.
Arribas JR; Instituto de Investigación Hospital Universitario La Paz, Hospital Universitario La Paz, Madrid, Spain.
Eron JJ Jr; Division of Infectious Diseases, Department of Medicine, UNC School of Medicine.
Wohl DA; Division of Infectious Diseases, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Clarke AE; Sexual Health and Clinical Trials, Royal Sussex County Hospital, Brighton, UK.
Sax PE; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Stellbrink HJ; Infectious Disease Medical Center, Hamburg.
Esser S; Universitatsklinikum, Essen, Germany.
Pozniak AL; Chelsea and Westminster Hospital and St Stephens AIDS Trust, London, UK.
Podzamczer D; Infectious Diseases Service, Hospital Universitario de Bellvitge, Barcelona, Spain.
Waters L; Mortimer Market Centre.
Orkin C; Barts Health NHS Trust, Ambrose King Centre, Royal London Hospital, London, UK.
Rockstroh JK; University Hospital Bonn, Bonn, Germany.
Mudrikova T; Department of Internal Medicine and Infectious Diseases, University Medical Center Utrecht, Utrecht, The Netherlands.
Negredo E; Universitat de Vic-Universitat Central de Catalunya, Barcelona, Spain.
Elion RA; Department of Clinical Investigations, Whitman-Walker Health, Washington, District of Columbia.
Guo S; Departments of Biometrics and HIV & Emerging Viral Infections Clinical Research, Gilead Sciences, Inc., Foster City, California, USA.
Zhong L; Departments of Biometrics and HIV & Emerging Viral Infections Clinical Research, Gilead Sciences, Inc., Foster City, California, USA.
Carter C; Departments of Biometrics and HIV & Emerging Viral Infections Clinical Research, Gilead Sciences, Inc., Foster City, California, USA.
Martin H; Departments of Biometrics and HIV & Emerging Viral Infections Clinical Research, Gilead Sciences, Inc., Foster City, California, USA.
Brainard D; Departments of Biometrics and HIV & Emerging Viral Infections Clinical Research, Gilead Sciences, Inc., Foster City, California, USA.
SenGupta D; Departments of Biometrics and HIV & Emerging Viral Infections Clinical Research, Gilead Sciences, Inc., Foster City, California, USA.
Das M; Departments of Biometrics and HIV & Emerging Viral Infections Clinical Research, Gilead Sciences, Inc., Foster City, California, USA.
Pokaż więcej
Źródło :
AIDS (London, England) [AIDS] 2019 Jul 15; Vol. 33 (9), pp. 1455-1465.
Typ publikacji :
Comparative Study; Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't
MeSH Terms :
Adenine/*analogs & derivatives
Anti-HIV Agents/*adverse effects
Renal Insufficiency/*chemically induced
Renal Insufficiency/*epidemiology
Tenofovir/*adverse effects
Adenine/administration & dosage ; Adenine/adverse effects ; Adolescent ; Adult ; Aged ; Aged, 80 and over ; Anti-HIV Agents/administration & dosage ; Child ; Female ; Humans ; Incidence ; Male ; Middle Aged ; Tenofovir/administration & dosage ; Young Adult
Czasopismo naukowe
Tytuł :
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study.
Autorzy :
Rodger AJ; Institute for Global Health, University College London, London, UK. Electronic address: .
Cambiano V; Institute for Global Health, University College London, London, UK.
Bruun T; Department of Infectious Diseases (CHIP), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Vernazza P; Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital, St Gallen, Switzerland.
Collins S; HIV i-Base, London, UK.
Degen O; University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
Corbelli GM; European AIDS Treatment Group, Brussels, Belgium.
Estrada V; Hospital Clinico San Carlos and Universidad Complutense, Madrid, Spain.
Geretti AM; Institute of Infection and Global Health, University of Liverpool, Liverpool, UK.
Beloukas A; Institute of Infection and Global Health, University of Liverpool, Liverpool, UK; Department of Biomedical Sciences, University of West Attica, Athens, Greece.
Raben D; Department of Infectious Diseases (CHIP), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Coll P; AIDS Research Institute-IrsiCaixa, Hospital Universitari Germans Trias i Pujol and BCN Checkpoint, Badalona and Barcelona, Spain.
Antinori A; Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani IRCCS, Rome, Italy.
Nwokolo N; Chelsea and Westminster NHS Foundation Trust, London, UK.
Rieger A; Medical University of Vienna, Vienna, Austria.
Prins JM; Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
Blaxhult A; Venhälsan, Södersjukhuset, Stockholm, Sweden.
Weber R; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Van Eeden A; DC Klinieken, Amsterdam, Netherlands.
Brockmeyer NH; Centre for Sexual Health and Medicine, Walk in Ruhr, Ruhr University Bochum, Bochum, Germany.
Clarke A; Brighton and Sussex University Hospitals NHS Trust, and Brighton and Sussex Medical School, Brighton, UK.
Del Romero Guerrero J; Centro Sanitario Sandoval, Madrid, Spain.
Raffi F; Infectious Diseases Department, University Hospital (Centre Hospitalier Universitaire de Nantes) Hotel-Dieu, and INSERM UIC 1413 Nantes University, Nantes, France.
Bogner JR; Medizinische Klinik und Poliklinik IV, University Hospital Munich, Munich, Germany.
Wandeler G; Department of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland.
Gerstoft J; Rigshospitalet, Copenhagen, Denmark.
Gutiérrez F; Hospital General de Elche and Universidad Miguel Hernández, Alicante, Spain.
Brinkman K; Onze Lieve Vrouwe Gasthuis (OLVG), Amsterdam, Netherlands.
Kitchen M; Medical University Innsbruck, Innsbruck, Austria.
Ostergaard L; Aarhus University Hospital, Skejby, Denmark.
Leon A; Hospital Clinic - IDIBAPS, University of Barcelona, Barcelona, Spain.
Ristola M; Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Jessen H; Praxis Jessen(2) + Kollegen, Berlin, Germany.
Stellbrink HJ; ICH Study Centre, Hamburg, Germany.
Phillips AN; Institute for Global Health, University College London, London, UK.
Lundgren J; Department of Infectious Diseases (CHIP), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Pokaż więcej
Corporate Authors :
PARTNER Study Group
Źródło :
Lancet (London, England) [Lancet] 2019 Jun 15; Vol. 393 (10189), pp. 2428-2438. Date of Electronic Publication: 2019 May 02.
Typ publikacji :
Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Homosexuality, Male*
Unsafe Sex*
Anti-HIV Agents/*therapeutic use
HIV Seropositivity/*transmission
Adult ; Antiretroviral Therapy, Highly Active ; Condoms ; Humans ; Male ; Middle Aged ; Prospective Studies ; Sexual Partners ; Viral Load
Czasopismo naukowe
Tytuł :
Co-formulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trial.
Autorzy :
Stellbrink HJ; Department of Internal Medicine, Infectious Diseases, University of Hamburg, Hamburg, Germany.
Arribas JR; Department of HIV and Infectious Diseases, Hospital Universitario La Paz, Madrid, Spain.
Stephens JL; Department of Internal Medicine, Mercer University School of Medicine, Macon, GA, USA.
Albrecht H; Department of Internal Medicine, University of South Carolina, Columbia, SC, USA.
Sax PE; Department of Medicine, Harvard Medical School, Boston, MA, USA.
Maggiolo F; Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.
Creticos C; Howard Brown Health Center, Chicago, IL, USA.
Martorell CT; Infectious Disease and The Research Institute, Springfield, MA, USA.
Wei X; Department of Biometrics, Gilead Sciences, Inc, Foster City, CA, USA.
Acosta R; Department of Virology, Gilead Sciences, Inc, Foster City, CA, USA.
Collins SE; Department of HIV Clinical Research, Gilead Sciences, Inc, Foster City, CA, USA. Electronic address: .
Brainard D; Department of HIV Clinical Research, Gilead Sciences, Inc, Foster City, CA, USA.
Martin H; Department of HIV Clinical Research, Gilead Sciences, Inc, Foster City, CA, USA.
Pokaż więcej
Źródło :
The lancet. HIV [Lancet HIV] 2019 Jun; Vol. 6 (6), pp. e364-e372. Date of Electronic Publication: 2019 May 05.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Anti-Retroviral Agents/*therapeutic use
HIV Infections/*drug therapy
HIV-1/*drug effects
Adenine/administration & dosage ; Adenine/analogs & derivatives ; Adult ; Anti-Retroviral Agents/administration & dosage ; Anti-Retroviral Agents/adverse effects ; Antiretroviral Therapy, Highly Active ; Drug Therapy, Combination ; Emtricitabine/administration & dosage ; Female ; Heterocyclic Compounds, 3-Ring/administration & dosage ; Heterocyclic Compounds, 4 or More Rings/administration & dosage ; Humans ; Male ; Middle Aged ; Tenofovir/administration & dosage ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Immediate Versus Deferred Switching From a Boosted Protease Inhibitor-based Regimen to a Dolutegravir-based Regimen in Virologically Suppressed Patients With High Cardiovascular Risk or Age ≥50 Years: Final 96-Week Results of the NEAT022 Study.
Autorzy :
Gatell JM; Hospital Clinic/Institut d'Investigacions Biomediques August Pi i Suñer, University of Barcelona and ViiV Healthcare, Spain.
Assoumou L; Institut national de la santé et de la recherche médicale (INSERM), Sorbonne Université, Institut Pierre Louis d'épidémiologie et de Santé Publique, Unite Medical pour la Recherche Scientifique 1136, Paris, France.
Moyle G; Chelsea and Westminster Hospital and St Stephens AIDS Trust, London, United Kingdom.
Waters L; Mortimer Market Center, London, United Kingdom.
Johnson M; Royal Free Hospital, London, United Kingdom.
Domingo P; Hospital de Sant Pau, Barcelona, Spain.
Fox J; Guys and St Thomas` Hospital, London, United Kingdom.
Martinez E; Hospital Clinic/Institut d'Investigacions Biomediques August Pi i Suñer, University of Barcelona and ViiV Healthcare, Spain.
Stellbrink HJ; Infektionsmedizinisches Study Centrum, Hamburg, Germany.
Guaraldi G; University of Modena and Reggio Emilia, Modena, Italy.
Masia M; Hospital de Elche, Spain.
Gompels M; Southmead Hospital, Bristol, United Kingdom.
De Wit S; Saint Pierre Hospital, Université Libre de Bruxelles, Brussels.
Florence E; Institute of Tropical Medicine, Antwerp, Belgium.
Esser S; Universitatsklinikum, Essen, Germany.
Raffi F; Infectious Diseases University Hospital and Centre d'Investigation Clinique, Unite d'Investigation Clinique 1413 INSERM, Centre Hopitalier Universitaire Nantes, France.
Stephan C; Klinikum der Goethe Universitat, Frankfurt.
Rockstroh J; Medizinische Klinik und Poliklinik, Bonn, Germany.
Giacomelli A; Hospital Luigi Sacco, Milan, Italy.
Vera J; Global Health and Infection, Brighton and Sussex Medical School, United Kingdom.
Bernardino JI; Hospital La Paz, Madrid, Spain.
Winston A; St Mary's Hospital, London, United Kingdom.
Saumoy M; Hospital de Bellvitge, Barcelona, Spain.
Gras J; Hopital St Louis.
Katlama C; Pitie-Salpetriere Hospital, Paris, France.
Pozniak AL; Chelsea and Westminster Hospital and St Stephens AIDS Trust, London, United Kingdom.
Pokaż więcej
Corporate Authors :
European Network for AIDS Treatment 022 (NEAT022) Study Group
Źródło :
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2019 Feb 01; Vol. 68 (4), pp. 597-606.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Antiretroviral Therapy, Highly Active/*methods
Drug Substitution/*methods
HIV Infections/*drug therapy
HIV Integrase Inhibitors/*administration & dosage
HIV Protease Inhibitors/*administration & dosage
Heterocyclic Compounds, 3-Ring/*administration & dosage
Lipids/*blood
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Cardiovascular Diseases/prevention & control ; Drug-Related Side Effects and Adverse Reactions/epidemiology ; Drug-Related Side Effects and Adverse Reactions/pathology ; Female ; HIV Integrase Inhibitors/adverse effects ; HIV Protease Inhibitors/adverse effects ; Heterocyclic Compounds, 3-Ring/adverse effects ; Humans ; Male ; Middle Aged ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł :
Antiretroviral switch studies do matter.
Autorzy :
Daar ES; Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA. Electronic address: .
Ruane P; Ruane Clinical Research Group, Los Angeles, CA, USA.
DeJesus E; Orlando Immunology Center, Orlando, FL, USA.
Stellbrink HJ; Infectious Disease Medical Center, Hamburg, Germany.
Molina JM; Department of Infectious Diseases, Saint-Louis Hospital, University of Paris Diderot, Paris, France.
Pokaż więcej
Źródło :
The lancet. HIV [Lancet HIV] 2018 Oct; Vol. 5 (10), pp. e546. Date of Electronic Publication: 2018 Oct 08.
Typ publikacji :
Letter; Comment
MeSH Terms :
HIV Infections*
Anti-HIV Agents ; Anti-Retroviral Agents ; Heterocyclic Compounds, 4 or More Rings ; Humans
Opinia redakcyjna

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies